OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.670
-0.040 (-2.34%)
At close: Nov 12, 2026, 4:00 PM EST
1.641
-0.029 (-1.73%)
After-hours: Nov 12, 2026, 7:59 PM EST
OPKO Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 654.1 | 606.88 | 713.14 | 863.5 | 1,004 | 1,775 | |
Revenue Growth | 90.77% | -14.90% | -17.41% | -14.01% | -43.42% | 23.64% |
Cost of Revenue | 525.69 | 524.97 | 599.85 | 634.96 | 789.86 | 1,270 |
Gross Profit | 128.41 | 81.91 | 113.3 | 228.53 | 214.33 | 504.67 |
Selling, General & Admin | 227.03 | 223 | 303.02 | 300.56 | 372.67 | 468.86 |
Research & Development | 4.73 | - | - | - | - | - |
Amortization of Goodwill & Intangibles | 78.15 | 77.89 | 82.63 | 86.03 | 87.78 | 50.28 |
Operating Expenses | 309.92 | 300.89 | 385.65 | 386.59 | 460.46 | 519.14 |
Operating Income | -181.51 | -218.99 | -272.36 | -158.06 | -246.12 | -14.46 |
Interest Expense | -47.16 | -108.46 | -47.47 | -13.51 | -12.06 | -18.88 |
Interest & Investment Income | 13.06 | 14.81 | 8.43 | 3.98 | 1.98 | 0.03 |
Earnings From Equity Investments | -5.02 | -0.03 | -0.02 | -0.11 | -0.38 | -0.63 |
Currency Exchange Gain (Loss) | 1.1 | -2 | -3.8 | 1.2 | -1.8 | -1.4 |
Other Non Operating Income (Expenses) | 1 | -28.06 | 164.69 | -18.42 | -149.83 | 3.46 |
EBT Excluding Unusual Items | -218.54 | -342.73 | -150.52 | -184.91 | -408.21 | -31.88 |
Gain (Loss) on Sale of Investments | 3.78 | -0.24 | 19.85 | -0.56 | -3.57 | -4.87 |
Gain (Loss) on Sale of Assets | 101.58 | 101.58 | 121.49 | - | 18.56 | 31.51 |
Asset Writedown | - | - | -1.2 | - | - | - |
Other Unusual Items | - | - | - | 1.04 | 1.31 | -9.41 |
Pretax Income | -113.18 | -241.39 | -10.38 | -184.43 | -391.9 | -14.65 |
Income Tax Expense | -5.4 | -15.71 | 42.84 | 4.44 | -63.5 | 15.49 |
Earnings From Continuing Operations | -107.78 | -225.68 | -53.22 | -188.86 | -328.41 | -30.14 |
Net Income | -148.06 | -225.68 | -53.22 | -188.86 | -328.41 | -30.14 |
Net Income to Common | -148.06 | -225.68 | -53.22 | -188.86 | -328.41 | -30.14 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 757 | 751 | 694 | 752 | 719 | 648 |
Shares Outstanding (Diluted) | 757 | 751 | 694 | 752 | 719 | 648 |
Shares Change | 3.81% | 8.23% | -7.68% | 4.55% | 10.95% | 1.16% |
EPS (Basic) | -0.20 | -0.30 | -0.08 | -0.25 | -0.46 | -0.05 |
EPS (Diluted) | -0.20 | -0.30 | -0.08 | -0.25 | -0.46 | -0.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -135.34 | -190.82 | -208.5 | -44.47 | -119.77 | 6.18 |
Free Cash Flow Per Share | -0.18 | -0.25 | -0.30 | -0.06 | -0.17 | 0.01 |
Gross Margin | 19.63% | 13.50% | 15.89% | 26.47% | 21.34% | 28.44% |
Operating Margin | -27.75% | -36.08% | -38.19% | -18.30% | -24.51% | -0.81% |
Profit Margin | -22.63% | -37.19% | -7.46% | -21.87% | -32.70% | -1.70% |
Free Cash Flow Margin | -20.69% | -31.44% | -29.24% | -5.15% | -11.93% | 0.35% |
EBITDA | -91.8 | -127.36 | -174.18 | -52.76 | -137.47 | 64.26 |
EBITDA Margin | -14.04% | -20.99% | -24.42% | -6.11% | -13.69% | 3.62% |
D&A For EBITDA | 89.71 | 91.63 | 98.18 | 105.3 | 108.66 | 78.72 |
EBIT | -181.51 | -218.99 | -272.36 | -158.06 | -246.12 | -14.46 |
EBIT Margin | -27.75% | -36.08% | -38.19% | -18.30% | -24.51% | -0.81% |
Revenue as Reported | 654.1 | 606.88 | 713.14 | 863.5 | 1,004 | 1,775 |